Tenderwize
Wróć do wyszukiwania

Open House Discount Agreement for Ribociclib

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 187 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ribociclib, ATC L01EF02

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

30 / 100

Czynniki ryzyka

Buyer may replace open-house agreements with exclusive discount contracts during the term, potentially terminating exis...

No guaranteed purchase volumes; financial benefit depends on market share and prescribing behavior.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount agreements for pharmaceutical products containing the active ingredient Ribociclib (ATC L01EF02).
  • Agreements cover the period from 01.05.2025 to 30.04.2027 (24 months maximum).
Pokaż pełne podsumowanie

This is an open-house procedure by AOK Rheinland-Pfalz/Saarland for non-exclusive discount agreements on the active ingredient Ribociclib (ATC L01EF02). The agreement is for a maximum of 24 months, starting 01.05.2025, with monthly accession possibilities. It is explicitly stated as not a public procurement under EU Directive 2014/24/EU, but published for transparency. No estimated value is provided. The procedure is open to all interested pharmaceutical companies with authorized and marketable medicines in Germany. The first submission deadline for a start on 01.05.2025 is 31.03.2025; later submissions can be made monthly. The buyer may replace these open-house agreements with exclusive discount contracts during the term.

Ryzyka

Buyer may replace open-house agreements with exclusive discount contracts during the term, potentially terminating exis...

No guaranteed purchase volumes; financial benefit depends on market share and prescribing behavior.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Medicines must be authorized and marketable in Germany.
  • Evidence of marketability via Lauer-Taxe listing or DIMDI AMIce database extracts.
  • Participation is open to all pharmaceutical companies; no selection or negotiation.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria explicitly specified; participation is open to all eligible companies meeting the conditions.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreement for Ribociclib

Non-exclusive discount agreements for Ribociclib (ATC L01EF02) under an open-house model. All interested pharmaceutical companies meeting the eligibility criteria can participate without selection. Contracts last up to 24 months, with start dates on the first of each month. The buyer may replace these with exclusive contracts during the term.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria explicitly specified; participation is open to all eligible companies meeting the conditions.

Termin

Deadline Feb 28, 2027

Szczegóły zamówienia

Data publikacji
20 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
184252-2025

Dokumenty (1)

Podobne przetargi